Vesicare Related Clinical Trials
Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy Volunteers [Completed]
VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate [Terminated]
A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet Formulation [Completed]
Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms [Completed]
Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder [Terminated]
Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects [Completed]
A Study to Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tamsulosin is Taken by Healthy Males Compared to Separate Tablets of Solifenacin and Tamsulosin [Completed]
Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients [Completed]
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease [Completed]
Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction [Completed]
Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease [Withdrawn]
Post Marketing Survey of Vesicare in Japan [Completed]
Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms [Completed]
Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder. [Completed]
A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB) [Completed]
Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects [Completed]
A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels [Completed]
Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder [Completed]
A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy [Completed]
Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin [Completed]
Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis [Completed]
Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) [Completed]
The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB) [Completed]
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients [Recruiting]
Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia [Completed]
A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simultaneously [Completed]
Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients [Recruiting]
A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients [Completed]
Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life [Completed]
A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks [Completed]
Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder [Not yet recruiting]
Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse [Terminated]
Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without Urgency [Completed]
A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder [Completed]
A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients [Completed]
Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder [Terminated]
A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men. [Completed]
A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence [Recruiting]
The Effect of Solifenacin on Post Void Dribbling in Women [Active, not recruiting]
A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) [Completed]
Effect of Electroacupuncture Versus PFMT Plus Solifenacin for Mixed Urinary Incontinence [Recruiting]
Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms [Recruiting]
Solifenacin Succinate Versus Tolterodine 4mg Once Daily [Completed]
Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder [Completed]
Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate) [Completed]
Therapy of the Overactive Bladder Syndrome [Recruiting]
A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosin When Administered in a Combination Tablet [Completed]
A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076 [Completed]
A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment [Completed]
Bacterial Genomic Sequencing in Overactive Bladder [Active, not recruiting]
A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO) [Suspended]
Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women [Completed]
A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug [Completed]
Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder [Not yet recruiting]
A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH [Completed]
A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental Ability [Completed]
Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms [Completed]
Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent Symptoms [Completed]
A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Patients 5 to 18 Years of Age With Neurogenic Detrusor Overactivity [Active, not recruiting]
A Study to Evaluate Whether Food Has an Effect on the Uptake of Solifenacin and Tamsulosin When Administered in a Combination Tablet [Completed]
The Efficacy of Solifenacin Succinate as Adjuvant Therapy for Urinary Tract Infection in Females [Recruiting]
A Study to Evaluate How Tamsulosin (at 1 Dose) and Solifenacin (at 2 Different Doses) Are Taken up From the Intestine, Distributed Through the Body and Eliminated From the Body When Administered in Combination as a Single Tablet (Called EC905) [Completed]
The PK Characteristics of the JLP-1207(Solifenacin/Tamsulosin 5mg/0.2mg) and Co-administration of Solifenacin and Tamsulosin in Healthy Male Volunteers. [Not yet recruiting]
Feasibility of "At-home" Titration of Solifenacin [Terminated]
Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms [Completed]
Over Active Bladder Patients Having Sling Surgery [Completed]
Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms [Completed]
Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit [Terminated]
Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow Parameters [Completed]
Anticholinergic vs. Botox Comparison Study [Completed]
Treatment of Symptoms in Male Patients With Lower Urinary Tract Symptoms (LUTS) Predominant Storage Symptoms (Overactive Bladder Syndrome) [Completed]
Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder [Not yet recruiting]
Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients [Recruiting]
Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers [Not yet recruiting]
InSite for Over Active Bladder [Active, not recruiting]
|
